From what I hear on various sites, I must be one of the
From what I hear on various sites, I must be one of the only believers in IPIX that has no remorse or worry when those I have told about it (and who are now in the red, some deep in the red) bitch about it. Why?
I told them right off the bat that biotech was the riskiest sector of investing possible. I stressed they only invest what they could afford to lose. I told them there was a major effort by unknown bodies to try and sabotage the future of IPIX, IMO these being BPs whose drugs are going to be made irrelevant by IPIXs.
On the other hand, I point to where IPIX is today, which IMO is right on the cusp of being wildly successful. IMO you have to risk big to win big. IPIX is one of the few that allows that dream to become a reality. I have staked a lot on this becoming true and hold little worry that it will fail.
I tell them don't bother me until we get word back on the upcoming human trial results for CV19. IMO that will be the first nut to crack with the OM and IBD trial successes following close behind. I tell them by the end of the year they could (not will, but could) see a return of their investment that will buckle their knees and by next Mar or so the return could make the end of the year price look like peanuts. A sure thing, no, but at this stage of the game a very, very, very good chance to happen.
So I end it with them at this juncture to just follow IPIX CLOSELY. When the news starts (and I believe the publicity starts in Sept) and things start percolating they should consider diving in and then it is their own responsibility to decide when to get out. As of now, anyone that invested within the last 18 months had the chance to earn a great return on their investment if they sold when prices were in the .50 range. Their greed kept them in, that is not my problem.
If some people lose a little money on IPIX, I will feel bad for them. If some never had the chance to make a fortune, I will feel terrible that I didn't allow them that opportunity by at least making it known to them.
I don't badger people to buy it, I just mention my investment if asked and say it is something they may want to follow. I do affirm I heartily recommend them to at least follow it.
9
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unraveling the Volato Merger Drama Boy, the plot thickens with Volato Group, Inc. (SOAR), and it ain’t the first time we’ve seen this kind of shuffle in the market. Now, Volato’s got itself tangled up with Alignment Engine Inc. through a proposed merger. Sounds routine at first; we all know mergers are part of the corporate game. But here's the twist—shareholders...
Continue Reading
Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....
Continue Reading
Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...
Continue Reading
Three Lions Joins the SPAC Playground The market's buzzing today as Three Lions Acquisition Corp. sauntered in with a $100M debut. Yep, they're the latest Special Purpose Acquisition Company out to net some big fish in the sports, hospitality, and real estate waters. A blank check company raising this kind of dough ain't exactly a novelty, but it never fails to turn a few...
Continue Reading
Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...
Continue Reading
Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...
Continue Reading
The K-Royal Culture Festival is rolling out in Fall 2026 with a flair that promises to capture the globetrotters' imaginations and then some. South Korea's signature national heritage jamboree is popping off from October 7 through October 11, 2026, at four magnificent palaces and the Jongmyo Shrine. If you're into discovering the depths of a place's history through...
Continue Reading
The Ongoing Alliance Between Finance and Football Well, color me intrigued. XTrend Speed's got their foot in two worlds—a top trading platform and now four years deep into supporting the Argentine Football Association. What's it all about? Primarily, this isn't merely about splashing logos across football kits. It's about syncing prestige, global reach, and excellence....
Continue Reading
Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...
Continue Reading
TVEyes Archive+ Takes Media Intelligence to New Heights Dishing out another update here, folks. TVEyes, the media intelligence powerhouse, just kicked off something that's got the potential to change the strategic media game—they call it Archive+. This tool isn’t just plundering old tapes; we're talking nearly two damn decades worth of historical broadcasts and...
Continue Reading
Top 5 Most Recently Viewed Articles
Celltrion's Groundbreaking Presentation at ACR Convergence 2024 Celltrion has made significant strides in biosimilar research, recently featuring compelling data at the American College of Rheumatology Convergence 2024. This event showcased their advancements with CT-P41, a biosimilar candidate of denosumab, and CT-P47, a biosimilar candidate of tocilizumab. These...
Continue Reading
Turning Losses into Profits in Cryptocurrency Trading In the volatile world of cryptocurrency, there are stories of immense gains and significant losses. One such story is that of a whale trader who experienced substantial losses in a digital asset called Dogwifhat. Despite facing a daunting challenge, this trader showed that resilience and strategic thinking can lead to...
Continue Reading
Revolutionizing Road Construction with Innovative Technologies Verde Resources Inc. (OTCQB: VRDR) and C-Twelve Pty Ltd are embarking on an exciting journey together, unveiling a groundbreaking 10-year exclusive partnership that promises to reshape the landscape of sustainable road construction. A Vision for Sustainable Infrastructure This partnership aims to introduce low...
Continue Reading
Helius Medical Technologies, Inc. Announces Successful Warrant Exercise Helius Medical Technologies, Inc. (Nasdaq:HSDT), a pioneer in neurotechnology dedicated to improving the lives of individuals with neurological conditions, has recently made an exciting announcement. The company has successfully entered into agreements to exercise existing warrants for 4,971,110...
Continue Reading
Aethon United BR LP, or simply Aethon United, is shaking things up with a fresh cash tender offer targeting its outstanding senior notes due in 2026. This play is all about tightening up their financial game, looking to boost operational agility and bolster overall fiscal health. Let’s break down what this means for noteholders and the company’s larger strategy....
Continue Reading